About
Tempus provides a platform combining comprehensive clinical and molecular data with artificial intelligence, primarily serving the oncology space. Their core offering is an operating system built upon the world’s largest library of such data, enhanced by recent advancements in generative AI like their clinical co-pilot, David, and digital pathology capabilities acquired through Paige. Tempus targets physicians, pharmaceutical companies, and patients seeking data-driven insights to improve cancer treatment decisions and accelerate drug development.
Stock Price
TEMTechnology Focus
Key People
Quick Stats
Explore More
Similar Companies
Genesis Therapeutics
Burlingame, United States
Exscientia
Oxford, United Kingdom
Healx
Cambridge, United Kingdom
Insilico Medicine
Hong Kong, Hong Kong